Primary Lymphedema (Stage I-II)

Patient Summary

Is this FDA-cleared for this use?

Not FDA-cleared for primary lymphedema. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational and adjunctive only.

What evidence exists?

Tier C (investigational). A small case series (n=18) reports limb-volume reductions of 7 to 12 percent at 12 weeks when leech sessions were added to complete decongestive therapy (CDT) in stage I-II primary lymphedema. There are no controlled trials. Primary lymphedema (Milroy disease, lymphedema praecox, lymphedema tarda) has distinct pathophysiology from secondary lymphedema — congenital lymphatic vessel malformation or hypoplasia. International Society of Lymphology stage I-II disease is conventionally managed with CDT (manual lymphatic drainage, multilayer compression bandaging, daily flat-knit garments, exercise, skin care). Surgical options (lymphovenous anastomosis, vascularized lymph node transfer) should be considered in stage III.

Main risks

• Bleeding from bite sites for 6 to 24 hours after detachment
• Bruising and tenderness over the affected limb for 7 to 14 days
• Cellulitis triggered by skin breakdown in an already lymph-compromised limb (this is the most serious risk specific to lymphedema patients)
• Aeromonas infection
• Worsening of limb volume from inflammation if the body responds with edema
• Allergic reaction to leech saliva
• Substitution for daily compression therapy or for skin-care routine
• Delay of surgical evaluation for stage III disease

Who should not consider this

• Patients with active cellulitis in the affected limb
• Patients with ISL stage III (elephantiasis) — surgical evaluation is primary
• Patients with hereditary syndromic lymphedema requiring genetic workup first
• Patients with open wounds, ulcers, or skin maceration in the affected limb
• Patients on anticoagulants or with severe anemia
• Patients who have not engaged with certified lymphedema therapy (CDT)

What to ask your clinician

• Is my lymphedema primary or secondary, and what stage (I, II, or III) is it?
• Am I receiving complete decongestive therapy from a certified lymphedema therapist?
• Am I wearing daily flat-knit compression garments?
• Have I been evaluated for surgical options (lymphovenous anastomosis, vascularized lymph node transfer) if I am stage III?
• Where exactly will the leech be placed, and what is the cellulitis-prevention plan?
• What is the realistic expected limb-volume change, given the small evidence base?

When to seek urgent care

• Sudden warmth, redness, swelling, or pain in the limb — possible cellulitis
• Fever above 38.0 C / 100.4 F, chills, or rigors
• Spreading redness, pus, or red streaks around any bite site
• Bleeding from a bite site lasting more than 24 hours
• Sudden rapid increase in limb circumference
• Hives, throat tightness, or breathing difficulty